Global Emergency Contraceptive Pills Market Research Report 2021

Emergency contraception is an important component of a comprehensive family planning program. It can help reduce the chance of unintended pregnancy following unprotected intercourse, contraceptive failure or misuse or in cases of sexual assault. It also helps to empower women, as it expands the method mix available to them and increases choice.
A key factor driving the growth of the market is the rise in number of initiatives to create awareness. With the surge in number of unplanned pregnancies across the globe, the governments and academic institutions are stepping in to promote the usage of contraception, including emergency contraceptive pills. They are launching initiatives to aid individual users in acquiring cost-effective contraception solutions.

The global Emergency Contraceptive Pills market was valued at US$ 954.3 million in 2019 and is expected to reach US$ 1062.6 million by the end of 2026, growing at a CAGR of 1.5% during 2021-2026.
This report focuses on Emergency Contraceptive Pills volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Emergency Contraceptive Pills market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Emergency Contraceptive Pills Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type
Combination Pills
Progesterone Pills
Estrogen Pills


Segment by Application
Drug Stores/ Pharmacy
Hospital Pharmacies
Online Traders
Others


By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E


By Company
HLL Life Care
Pfizer
Syzygy Healthcare
V Care Pharma
Allergan
Lupin
Mankind
Piramal
Teva
Bayer AG
Zhejiang Xianju Pharmaceutical Co